ArticleInternational journal of hematology2021
A simple method to distinguish residual elotuzumab from monoclonal paraprotein in immunofixation assays for multiple myeloma patients.
Shurui Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.